What You Should Know
- Targeted drugs have replaced chemotherapy for most people with chronic lymphocytic leukemia (CLL), although chemotherapy-based treatment may still be considered in rare situations — a shift reflected across major guidelines updated between 2023 and 2025.
- Dr. Farrukh Awan, a hematologist-oncologist at UT Southwestern Medical Center in Dallas, stresses that the key question for newly diagnosed patients isn’t which drug to use, but when treatment is actually needed, since iwCLL criteria rely on a mix of symptom‑based and objective findings rather than any single lab value.
- A rising white blood cell count alone doesn’t trigger treatment; instead, physicians look for meaningful symptoms, specific lab thresholds, and rapid lymphocyte doubling, with time‑limited regimens increasingly favored once treatment becomes necessary.
“We don’t use chemotherapy. It should not be used,” Dr. Awan tells SurvivorNet. “Outside of a protocol of some sort, chemotherapy has no role for CLL if you have access to all the new drugs.”
Read MoreThe Real Question: Not ‘What,’ But ‘When’
After a cancer diagnosis, patients understandably have a multitude of questions during this period of uncertainty, with treatment being one of them. Dr. Awan says the more important question for newly diagnosed patients, however, isn’t which drug to use, but rather, whether treatment is even needed at all. “When do we treat patients — that’s more important than what do you treat them with,” he stresses. “There are clear criteria for treating patients, and these are based on international consensus recommendations of all the CLL experts in the world.”Those criteria — formally known as the iwCLL (International Workshop on CLL) guidelines — break down into two categories, as Dr. Awan explains: subjective, symptom-based criteria, and objective, lab- and exam-based criteria.
The Subjective Criteria: Symptoms That Signal It’s Time
Dr. Awan describes several symptoms that patients should look out for, and report any of the following symptoms immediately to your doctor:
- Fevers and night sweats — but not just feeling warm at night. “It’s really drenching night sweats multiple times a week when you have to wake up and change your clothes… or change the bedsheets,” he says. The iwCLL specifies night sweats for more than 1 month without evidence of infection as a qualifying symptom.
- Symptomatic lymph nodes — a lump causing trouble swallowing, coughing, pain, or discomfort.
- Unintentional weight loss — the iwCLL criteria define this specifically as weight loss of more than 10% within the previous 6 months.
- Fatigue that’s out of proportion to normal aging or daily stress, and that can’t be explained by another cause. “If the thyroid is the issue or the hormones are an issue, then fixing the CLL won’t fix the fatigue issue,” Dr. Awan notes, which is why doctors work to rule out other explanations before attributing fatigue to CLL itself.
The Objective Criteria: What the Numbers Actually Mean
Even when a patient feels fine, certain lab and physical findings can trigger a treatment discussion. Dr. Awan cites hemoglobin (a protein in the red blood cells), platelet count (the number of platelets, tiny blood cells that help blood clot after injury), spleen size (a small organ that filters and stores blood), and lymph node size (organs that help fight disease and infection, “and there are cutoffs for all of that.”
These metrics closely track iwCLL thresholds:
- Hemoglobin dropping below 10 g/dL
- Platelet counts falling below 100 × 10⁹ per liter
- Spleen enlargement more than 6 cm below the costal margin
- Lymph nodes reaching 10 cm or more in diameter, or growing progressively
Expert Resources for CLL Patients
- CLL Treatment: The Side Effects to Expect & Why Reporting All New Symptoms is Crucial
- CLL is Not Considered Curable So Treatment May Resume Years Later
- CLL Treatment Decision Making — Exploring All Your Options To Find What’s Right For You
- BTK Inhibitors: Finding The Right Fit For Chronic Lymphocytic Leukemia (CLL) Patients
- BTK Inhibitors Play An Important Role In CLL Treatment & Management
The One Number That Doesn’t Matter as Much as People Think
Patients often assume a rising white blood cell count is the trigger for treatment. However, Dr. Awan emphatically says that it isn’t.
“One most important thing that we cannot stress enough is there’s no magic number for the white count,” he says. “There is no such thing as a white count threshold,” Dr. Awan tells SurvivorNet.
A high lymphocyte count alone does not require treatment. However, treatment may be considered if the count increases by at least 50% within two months or doubles within six months, after doctors rule out other possible causes, such as an infection.
Dr. Awan adds using illustrative examples rather than published data points: “Some people at 10,000 may have really bad symptoms. Some people at 100,000 may be completely without symptoms.”
Where Treatment Is Heading
Once a patient does meet criteria for treatment, Dr. Awan says the field is increasingly favoring a “time-limited treatment.”
Recent National Comprehensive Cancer Network (NCCN) guideline updates note that time-limited treatment with BCL2-inhibitor-containing regimens resulted in higher rates of undetectable measurable residual disease than BTK-inhibitor monotherapy or chemoimmunotherapy, giving physicians a data-driven reason to favor fixed-duration treatment when appropriate.
What This Means for Patients
A CLL diagnosis doesn’t come with a single trigger number that tells a patient or doctor when to start treatment. Instead, it’s a judgment call built on well-defined, internationally agreed-upon criteria — a combination of how a patient feels and what their bloodwork and exam show.
Dr. Awan frames it as “a lot of judgment call,” but one guided by clear, consensus-based standards rather than guesswork.
Questions to Ask Your Doctor
- Do I currently meet the accepted criteria for starting CLL treatment?
- Are my blood counts stable, or are they worsening over time?
- Could my symptoms or abnormal test results have another cause?
- What changes should prompt me to contact you before my next appointment?
- If I need treatment, would continuous or fixed-duration therapy be more appropriate for me?
Learn more about SurvivorNet's rigorous medical review process.
